Claim
descriptive

About one in three children with Graves' disease who start on anti-thyroid drugs eventually need surgery or radioactive iodine because the drugs alone don't cure their condition.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses

A systematic review could determine the pooled proportion of children requiring definitive therapy after ATD failure across international settings.

A systematic review and meta-analysis of cohort studies reporting the proportion of children with Graves' disease who eventually received radioactive iodine or thyroidectomy after initial ATD therapy, including only studies with ≥5 years follow-up and standardized definitions of definitive treatment.

2
Randomized Controlled Trials

An RCT could test whether early definitive therapy reduces long-term complications compared to prolonged ATD, but cannot change the natural proportion requiring it.

A multicenter RCT assigning 500 children with Graves' disease to either immediate radioactive iodine or 2 years of ATD, with primary outcome being cumulative incidence of definitive therapy at 5 years, to determine if early intervention reduces later need.

3
Cohort Studies
In Evidence

A prospective cohort could confirm the proportion requiring definitive therapy in a new population under standardized care.

A prospective cohort following 600 children with Graves' disease treated with ATD for at least 2 years, tracking whether they later received radioactive iodine or thyroidectomy, with outcomes recorded annually for 10 years.

4
Case-Control Studies

A case-control study could compare characteristics of children who received definitive therapy versus those who did not, but is not ideal for prevalence estimation.

A case-control study comparing 150 children who received definitive therapy with 150 who achieved remission, matched for age and diagnosis year, to identify predictors of definitive treatment need.

5
Cross-Sectional Studies

A cross-sectional survey could estimate the proportion of children with prior Graves' disease who have undergone definitive therapy.

A cross-sectional survey of 1000 adults who had Graves' disease in childhood, asking whether they received radioactive iodine or thyroidectomy, with medical record verification, to estimate the cumulative proportion undergoing definitive therapy.

Sign up to see full verdict